51131614 Anisindione

Definition

UNSPSC 51131614

This classification denotes an anticoagulant agent with the molecular formula C16H12O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S747T1ERAJ, chemically known as 1,3-indanedione, 2-(4-methoxyphenyl)- but generally known as anisindione, which bears US NIH Compound Identifier 2197. European Medicines Agency schedules Anisindione in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05520MIG. The term ANISINDIONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). ANISINDIONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule anisindione under HS 29145000 and SITC 51629. As of Q4 2014, ANISINDIONE remains the US FDA Preferred Term for this commodity. Anisindione bears US NLM identifiers UMLS ID C0051919 and NCI Concept Code C47398. SMILES: O=C1C(C(=O)C2C1CCCC2)C1CCC(OC)CC1.

Same parent

Under 51131600 · 61

51131602 Heparin Commodity 51131604 Warfarin Commodity 51131605 Sodium citrate Commodity 51131606 Sodium apolate Commodity 51131607 Enoxaparin Commodity 51131608 Lepirudin Commodity 51131609 Desirudin Commodity 51131610 Ardeparin Commodity 51131611 Dalteparin Commodity 51131613 Dicoumarol or dicumarol Commodity 51131614 Anisindione You are here 51131615 Fondaparinux Commodity 51131617 Anticoagulant citrate phosphate dextrose solution Commodity 51131618 Beraprost Commodity 51131619 Acenocoumarol Commodity 51131620 Anagrelide hydrochloride Commodity 51131621 Apixaban Commodity 51131622 Aprosulate Commodity 51131623 Beciparcil Commodity 51131624 Dabigatran etexilate mesilate Commodity 51131625 Bivalirudin Commodity 51131626 Camonagrel Commodity 51131627 Cangrelor Commodity 51131628 Citric acid Commodity 51131629 Clopidogrel Commodity 51131630 Clorindione Commodity 51131631 Dabigatran Commodity 51131632 Diarbarone Commodity 51131633 Diphacinone or diphenadione Commodity 51131634 Ditazol or ditazole Commodity 51131635 Ecraprost Commodity 51131636 Efegatran Commodity 51131637 Etabenzarone Commodity 51131638 Ethyl biscoumacetate Commodity 51131639 Fradafiban Commodity 51131640 Gabexate Commodity 51131641 Nadroparin Commodity 51131642 Iloprost Commodity 51131643 Indobufen Commodity 51131644 Melagatran Commodity 51131645 Moxicoumone Commodity 51131646 Napsagatran Commodity 51131647 Phenindione Commodity 51131648 Phenprocoumon Commodity 51131649 Prasugrel Commodity 51131650 Rivaroxaban Commodity 51131651 Sulmarin Commodity 51131652 Sulotroban Commodity 51131653 Ticlopidine Commodity 51131654 Tioclomarol Commodity 51131655 Tulopafant Commodity 51131656 Vapiprost Commodity 51131657 Ximelagatran Commodity 51131658 Xylocoumarol Commodity 51131659 Ancrod Commodity 51131660 Danaparoid Commodity 51131661 Drotrecogin alfa Commodity 51131662 Parnaparin Commodity 51131663 Dabigatran etexilate Commodity 51131664 Antithrombin Commodity 51131665 Acetylsalicylic acid/Clopidogrel bisulfate Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51130000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class